Germany’s Activaero Inks $6.8M
Activaero GmbH, a German developer of controlled breathing inhalation devices, has raised 5 million euro ($6.8 million) in venture capital financing. Amsterdam-based LSP Life Sciences Partners led the round with a 3.5 million euro investment. The firm was joined by existing shareholders including BioMedPartners, VI Partners, Abalis Finance, Vesalius Biocapital I SICAR, MedVenture Partners.
16 February 2011•2 mins read
